3.18 USD
↗ 0.00 (0.00%)PRE MARKET (AS OF 07:17 AM EDT)
Cerus Corp
CERSNASDAQ • USD
Market: OPEN
CERS is currently priced at $3.18. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, CERS trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 15, 2026.
Open?$3.19
High?$3.27
Low?$3.19
Prev. Close?$3.18
Volume?120
Avg. Volume?2.7M
VWAP?$3.26
Rel. Volume?0.00x
Bid / Ask
Bid?$2.70 × 100
Ask?$3.71 × 100
Spread?$1.01
Midpoint?$3.21
Valuation & Ratios
Market Cap?637.2M
Shares Out?200.4M
Float?190.8M
Float %?95.2%
P/E Ratio?N/A
P/B Ratio?9.43
EPS?-$0.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Employees
345
Market Cap
615.1M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
1997-01-31
Address
1220 CONCORD AVENUE
CONCORD, CA 94520
Phone: (925) 288-6000
CONCORD, CA 94520
Phone: (925) 288-6000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?73
Short Sent.?59
Piotroski F-Score?3/9Weak
Altman Z-Score?-2.91Distress
Confidence?54%Low
Short InterestElevated
Short % of Float?6.68%Elevated
Short Interest?12.7M
Days to Cover?4.1
Free Float190.8M
Avg Daily Volume3.1M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.63Adequate
Quick Ratio?1.06Adequate
Cash Ratio?0.26Low
Debt/Equity?1.26Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?9.43HIGH▾
Peers100
S&P20
P/S?2.60CHEAP▾
Peers100
S&P56
P/FCF?N/A▾
EV/EBITDA?-429.6CHEAP▾
S&P97
EV/Sales?2.84CHEAP▾
Peers100
S&P63
Returns & Efficiency
ROE?-14.1%WEAK▾
S&P9
ROA?-4.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-1218000
Enterprise Value?$694.2M
Fundamentals ratios updated end of day